Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Severe tumefactive rebound of multiple sclerosis following fingolimod cessation.
Interferon-β therapy specifically reduces pathogenic memory B cells in Multiple Sclerosis patients by inducing a FAS-mediated apoptosis.
Multiple sclerosis should be treated using a step-down strategy rather than a step-up strategy-YES.
Do coping strategies mediate the association between Type D personality and quality of life among people with multiple sclerosis?
The effectiveness of the Permission, Limited Information, Specific suggestions, Intensive Therapy (PLISSIT) model based sexual counseling on the sexual function of women with Multiple Sclerosis who are sexually active.
Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases.
Melatonin reverses H-89 induced spatial memory deficit: Involvement of oxidative stress and mitochondrial function.
Disease activity in chronic inflammatory demyelinating polyneuropathy.
Rabies virus-mediated oligodendrocyte labeling reveals a single oligodendrocyte myelinates axons from distinct brain regions.
High-Resolution Expression Profiling of Peripheral Blood CD8(+) Cells in Patients with Multiple Sclerosis Displays Fingolimod-Induced Immune Cell Redistribution.
Polyomaviruses.
Hippocampal microstructural damage correlates with memory impairment in clinically isolated syndrome suggestive of multiple sclerosis.
T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis.
Pur-Alpha Induces JCV Gene Expression and Viral Replication by Suppressing SRSF1 in Glial Cells.
Dopa-responsive acute disseminated encephalomyelitis with marked atrophy of the striate body.
Re: The effect of venous anatomy on the morphology of multiple sclerosis lesions: a susceptibility-weighted imaging study. A reply.
Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4.
Fingolimod suppresses bone resorption in female patients with multiple sclerosis.
Neurodegeneration in multiple sclerosis and neuromyelitis optica.
Comparison of Personal Resources in Patients Who Differently Estimate the Impact of Multiple Sclerosis.
Evolution of Myelin Proteins.
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis.
Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study.
Defining and scoring response to IFN-β in multiple sclerosis.
Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod.
Pages
« first
‹ previous
…
723
724
725
726
727
728
729
730
731
…
next ›
last »